Spirea
New generation of antibody drug conjugate (ADC) therapeutics
Spirea has raised €2.9M across 1 funding round from 7 investors, most recently a round in Jun 2022. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKwww.spirea.co.uk ↗
Total raised
€2.9M
€2,870,264
Funding rounds
1
Investors
7
distinct backers
Active since
2022-06
latest 2022-06
Funding by year
EUR raised per yearSpirea — funding by year — interactive chart.
Data table
| Spirea — funding by year | |
|---|---|
| 2022 | €2.9M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-14 | Other | €2.9M | ACF investors,Cambridge Angels,Cambridge Enterprise,Jonathan Milner,o2h Ventures,R42 Group+1 more | View deal → |